<DOC>
	<DOCNO>NCT01438658</DOCNO>
	<brief_summary>Uveal melanoma common primary intraocular tumor adult . The local treatment effective , patient still die metastatic disease . It show early diagnosis isolate metastasis result clean surgical excision metastasis extension expect survival 7-12 month 10 year patient . Many serum biomarkers employ Oncology . It make sense try relevant one diagnosis metastatic uveal melanoma . The investigator hypothesis soluble serum biomarker level change upon development metastatic disease either secretion tumor cell environment . Detection change biomarker level may lead diagnosis metastasis detect image modality , thus allow early treatment metastasis well chance success .</brief_summary>
	<brief_title>Assessing Clinical Effectiveness Serum Biomarkers Diagnosis Metastatic Uveal Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Uveal Neoplasms</mesh_term>
	<criteria>diagnosis uveal melanoma refusal participate study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>uveal melanoma</keyword>
	<keyword>metastatic uveal melanoma</keyword>
</DOC>